This was also further elucidated in a recent AD GWAS, where another IL1RL1/rs1921622 variant was found to have protective effects in female APOE4 carrier participants by suppressing the soluble receptor that inactivates the microglial response to amyloid beta [42]. Here, APOE is linked to Alzheimer disease.